Skip to content

Selective Triple Negative Breast Cancer Therapy

A compound that selectively decreases chemoresistance in triple negative tumours and other highly aggressive metastatic malignancies

Published: 28th January 2020
Selective Triple Negative Breast Cancer Therapy
Please note, header image is purely illustrative. Source: NutritionFacts.org-Youtube-CCby2.0
Patents
  • U.S. Granted patent US10,201,610 B2 entitled “Interference Peptides and Use Thereof”. Other iPeps against transcription factors have also been protected/are being developed.
IP Status
  • Patent application submitted
  • Patented
Seeking
  • Licensing
  • Development partner